Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s compe ...

Supplements for weight loss include vitamins, minerals, herbs, amino acids, and fibers marketed to help patients drop weight by reducing appetite, strengthening metabolism, and increasing fat burn ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this experimental weight loss pill as a potential global breakthrough treatment ...

Weight loss prescriptions come in numerous forms, including pills, injections and supplements. We’re focusing on pills in this article but want to call out some of the differences.

In This Article, You’ll Discover:The real reasons women struggle with weight loss, including hormonal, metabolic, and emotional factorsHow to identify the most effective female diet pills based ...

Share on Pinterest A Wegovy weight loss pill from Novo Nordisk is forthcoming, providing an alternative to injectable GLP-1 drugs. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty Images Federal ...

Now, a new contender is stepping into the spotlight. It’s called Orforglipron, and it’s a daily weight loss pill that could be a game-changer in how we manage both weight and blood sugar.

Eli Lilly, the maker of Ozempic, has developed a weight loss pill that could work as well. The new weight loss pill, orforglipron, is a once-daily oral GLP-1 receptor agonist that is designed to ...